Latest News

Keep up to date with the latest news from Pilatus Biosciences.

News

October 2025

Pilatus Biosciences to Present New Preclinical Data Highlighting PLT012’s Ability to Induce Durable Anti-Tumor Immunity Through Immunometabolic Reprogramming of the Tumor Microenvironment at SITC 2025 Annual Meeting

October 2025

Pilatus Biosciences Announces Issuance of Foundational Global Patent Covering Novel CD36-Targeted Immunotherapy

August 2025

Pilatus Biosciences Announces Clinical Trial Collaboration with Roche to Evaluate PLT012 in First-in-Human Study in Hepatocellular Carcinoma

April 2025

Pilatus Biosciences Publishes Preclinical Data in Cancer Discovery on PLT012 First-in-Class CD36-Targeting Antibody for Liver Cancer

Upcoming Events

Currently, there are no scheduled upcoming events.